AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/250
RAPIDLY ALTERNATING COPP PLUS ABV PLUS IMEP (CAI) IS EQUALLY EFFECTIVE AS ALTERNATING COPP PLUS ABVD (CA) FOR HODGKINS-DISEASE - FINAL RESULTS OF 2 RANDOMIZED TRIALS FOR INTERMEDIATE (HD5 PROTOCOL) AND ADVANCED (HD6 PROTOCOL) STAGES
Authors: SIEBER M RUEFFER U TESCH H LIEBERZ D PAULUS U BROSTEANU O LOEFFLER M PFREUNDSCHUH M LATHAN B DUHMKE E GEORGII A HILLER E KOCH P DOLKEN G CERNY T CARTONI C MANDELLI F DIEHL V
Citation: M. Sieber et al., RAPIDLY ALTERNATING COPP PLUS ABV PLUS IMEP (CAI) IS EQUALLY EFFECTIVE AS ALTERNATING COPP PLUS ABVD (CA) FOR HODGKINS-DISEASE - FINAL RESULTS OF 2 RANDOMIZED TRIALS FOR INTERMEDIATE (HD5 PROTOCOL) AND ADVANCED (HD6 PROTOCOL) STAGES, Blood, 90(10), 1997, pp. 2605-2605
BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA IN LONG-LASTING SYSTEMICLUPUS-ERYTHEMATOSUS - REGRESSION OF BOTH DISEASES AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: MELONI G CAPRIA S VIGNETTI M MANDELLI F MODENA V
Citation: G. Meloni et al., BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA IN LONG-LASTING SYSTEMICLUPUS-ERYTHEMATOSUS - REGRESSION OF BOTH DISEASES AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 89(12), 1997, pp. 4659-4659
OCULAR MANIFESTATIONS IN HIV-RELATED LYMPHOMA PATIENTS - INFLUENCE OFLYMPHOMA AND RELATED TREATMENT
Authors: PIVETTIPEZZI P ACCORINTI M GASTALDI R TAMBURI S GENTILE G MANDELLI F
Citation: P. Pivettipezzi et al., OCULAR MANIFESTATIONS IN HIV-RELATED LYMPHOMA PATIENTS - INFLUENCE OFLYMPHOMA AND RELATED TREATMENT, Annals of ophthalmology. Glaucoma, 28(4), 1996, pp. 227-234
HEPATITIS-B AND HEPATITIS-C VIRUSES, HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II, AND LEUKEMIAS - A CASE-CONTROL STUDY
Authors: GENTILE G MELE A MONARCA B VITALE A PULSONI A VISANI G CASTELLI G RAPICETTA M VERANI P MARTINO P MANDELLI F TREMATERRA M VILLANO U FERRIGNO L IANTOSCA G DACAS R BERNASCONI C MERANTE S TURA S COLOMBINI R CAPOBIANCHI A ROLLI M DONATI PPP SANTILLI S
Citation: G. Gentile et al., HEPATITIS-B AND HEPATITIS-C VIRUSES, HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II, AND LEUKEMIAS - A CASE-CONTROL STUDY, Cancer epidemiology, biomarkers & prevention, 5(3), 1996, pp. 227-230
INTERLEUKIN-2 FOR THE TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH LIMITED DISEASE - UPDATED EXPERIENCE WITH 20 CASES
Authors: MELONI G VIGNETTI M ANDRIZZI C CAPRIA S FOA R MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 FOR THE TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH LIMITED DISEASE - UPDATED EXPERIENCE WITH 20 CASES, Leukemia & lymphoma, 21(5-6), 1996, pp. 429-435
HIGH-INCIDENCE OF INFECTIOUS GASTROINTESTINAL COMPLICATIONS OBSERVED IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA RECEIVING INTENSIVE CHEMOTHERAPY FOR FIRST INDUCTION OF REMISSION
Authors: MICOZZI A CARTONI C MONACO M MARTINO P ZITTOUN R MANDELLI F
Citation: A. Micozzi et al., HIGH-INCIDENCE OF INFECTIOUS GASTROINTESTINAL COMPLICATIONS OBSERVED IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA RECEIVING INTENSIVE CHEMOTHERAPY FOR FIRST INDUCTION OF REMISSION, Supportive care in cancer, 4(4), 1996, pp. 294-297
OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS
Authors: LISO V IACOPINO P AVVISATI G PETTI MC BROCCIA G CAROTENUTO M FALDA M FAZI P LAZZARINO M LEONI P MIRTO S PUCCI G NOBILE F NOSARI AM SPECCHIA G STASI R TABILIO A MANDELLI F
Citation: V. Liso et al., OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS, Leukemia, 10(9), 1996, pp. 1443-1452
IMPROVED RAPID DETECTION OF THE PML RAR-ALPHA FUSION GENE IN ACUTE PROMYELOCYTIC LEUKEMIA/
Authors: DIVERIO D RICCIONI R PISTILLI A BUFFOLINO S AVVISATI G MANDELLI F LOCOCO F
Citation: D. Diverio et al., IMPROVED RAPID DETECTION OF THE PML RAR-ALPHA FUSION GENE IN ACUTE PROMYELOCYTIC LEUKEMIA/, Leukemia, 10(7), 1996, pp. 1214-1216
A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA
Authors: AMADORI S PICARDI A FAZI P TESTI AM PETTI MC MONTEFUSCO E MANDELLI F
Citation: S. Amadori et al., A PHASE-II STUDY OF VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN (VAC) IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA AND BLASTIC CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 10(5), 1996, pp. 766-768
CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE IN PH-POSITIVE CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON
Authors: ALIMENA G LAZZARINO M MORRA E MANCINI M CEDRONE M MONTEFUSCO E MERANTE S MELONI G BERNASCONI P RONDINELLI MB BERNASCONI C MANDELLI F
Citation: G. Alimena et al., CLINICAL AND CYTOLOGIC CHARACTERISTICS OF BLASTIC PHASE IN PH-POSITIVE CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON, Leukemia, 10(4), 1996, pp. 615-618
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP
Authors: ZITTOUN R SUCIU S MANDELLI F DEWITTE T THALER J STRYCKMANS P HAYAT M PEETERMANS M CADIOU M SOLBU G PETTI MC WILLEMZE R
Citation: R. Zittoun et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP, Journal of clinical oncology, 14(7), 1996, pp. 2150-2159
ANAPLASTIC LARGE-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC EVALUATION OF 90 ADULT PATIENTS
Authors: ZINZANI PL BENDANDI M MARTELLI M FALINI B SABATTINI E AMADORI S GHERLINZONI F MARTELLI MF MANDELLI F TURA S PILERI SA
Citation: Pl. Zinzani et al., ANAPLASTIC LARGE-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC EVALUATION OF 90 ADULT PATIENTS, Journal of clinical oncology, 14(3), 1996, pp. 955-962
HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY
Authors: MARTELLI M VIGNETTI M ZINZANI PL GHERLINZONI F MELONI G FIACCHINI M DESANCTIS V PAPA G MARTELLI MF CALABRESI F TURA S MANDELLI F
Citation: M. Martelli et al., HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY, Journal of clinical oncology, 14(2), 1996, pp. 534-542
LONG-TERM RESULTS OF TREATMENT OF CHILDHOOD AND ADOLESCENT HODGKINS-DISEASE IN 73 PATIENTS - THE EXPERIENCE OF THE DEPARTMENT-OF-RADIOLOGY AND DEPARTMENT-OF-HEMATOLOGY OF THE UNIVERSITY-OF-ROME-LA-SAPIENZA
Authors: ENRICI RM ANSELMO AP OSTI MF SBARBATI S TOMBOLINI V CARTONI C MANDELLI F BIAGINI C
Citation: Rm. Enrici et al., LONG-TERM RESULTS OF TREATMENT OF CHILDHOOD AND ADOLESCENT HODGKINS-DISEASE IN 73 PATIENTS - THE EXPERIENCE OF THE DEPARTMENT-OF-RADIOLOGY AND DEPARTMENT-OF-HEMATOLOGY OF THE UNIVERSITY-OF-ROME-LA-SAPIENZA, Haematologica, 81(3), 1996, pp. 245-252
INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS
Authors: DEWITTE T SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J
Citation: T. Dewitte et al., INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS, Experimental hematology, 24(9), 1996, pp. 678-678
BAVC REGIMEN AND AUTOGRAFT FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND COMPLETE REMISSION
Authors: MELONI G VIGNETTI M AVVISATI G CAPRIA S MICOZZI A GIONA F MANDELLI F
Citation: G. Meloni et al., BAVC REGIMEN AND AUTOGRAFT FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND COMPLETE REMISSION, Bone marrow transplantation, 18(4), 1996, pp. 693-698
PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL
Authors: KEATING S SUCIU S DEWITTE T MANDELLI F WILLEMZE R RESEGOTTI L BROCCIA G THALER J LABAR B DAMASIO E BIZZI B ROTOLI B VEKHOFF A MUUS P PETTI MC DARDENNE M SOLBU G VEGNA ML ZITTOUN R
Citation: S. Keating et al., PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 17(6), 1996, pp. 993-1001
RISK-FACTORS FOR ESSENTIAL THROMBOCYTHEMIA - A CASE-CONTROL STUDY
Authors: MELE A VISANI G PULSONI A MONARCA B CASTELLI G STAZI MA GENTILE G MANDELLI F RASCHETTI R IANTOSCA G DACAS R FERRIGNO L VITALE A VEGNA ML MARTINO P MERANTE S BERNASCONI CB LIVRAGHI A BONI M COLOMBINI R GUGLIOTTA L TURA S
Citation: A. Mele et al., RISK-FACTORS FOR ESSENTIAL THROMBOCYTHEMIA - A CASE-CONTROL STUDY, Cancer, 77(10), 1996, pp. 2157-2161
TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON
Authors: PETTI MC LATAGLIATA R AVVISATI G SPIRITI MAA MONTEFUSCO E SPADEA A MANDELLI F
Citation: Mc. Petti et al., TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON, British Journal of Haematology, 95(2), 1996, pp. 364-367
THE GIMEMA-ALL-0183 TRIAL - ANALYSIS OF 10-YEAR FOLLOW-UP
Authors: MANDELLI F ANNINO L ROTOLI B
Citation: F. Mandelli et al., THE GIMEMA-ALL-0183 TRIAL - ANALYSIS OF 10-YEAR FOLLOW-UP, British Journal of Haematology, 92(3), 1996, pp. 665-672
AIDA (ALL-TRANS-RETINOIC ACID PLUS IDARUBICIN) IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - A -ITALIANO-MALATTIE-EMATOLOGICHE-MALIGNE-DELLADULTO (GIMEMA) PILOT-STUDY
Authors: AVVISATI G LOCOCO F DIVERIO D FALDA M FERRARA F LAZZARINO M RUSSO D PETTI MC MANDELLI F
Citation: G. Avvisati et al., AIDA (ALL-TRANS-RETINOIC ACID PLUS IDARUBICIN) IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - A -ITALIANO-MALATTIE-EMATOLOGICHE-MALIGNE-DELLADULTO (GIMEMA) PILOT-STUDY, Blood, 88(4), 1996, pp. 1390-1398
MOLECULAR CONTROL OF CELL-CYCLE IN NORMAL AND NEOPLASTIC HEMATOPOIESIS - P16, CDK4, AND RB SHOWED A COMMON TUMORIGENESIS PATTERN IN ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: PETRUCCI MT ARIOLA C RICCIARDI MR PISEGNA S FIMIA GM ANNINO L TESTI AM LOCOCO F MANDELLI F TAFURI A
Citation: Mt. Petrucci et al., MOLECULAR CONTROL OF CELL-CYCLE IN NORMAL AND NEOPLASTIC HEMATOPOIESIS - P16, CDK4, AND RB SHOWED A COMMON TUMORIGENESIS PATTERN IN ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 3206-3206
THROMBOPOIETIN PROLIFERATIVE EFFECTS ON ACUTE MYELOID-LEUKEMIA CELLS
Authors: TAFURI A RICCIARDI MR LEMOLI RM FORTUNA A BONSI L STRIPPOLI PL ARIOLA C MAZZOLA F PETRUCCI MT MANDELLI F BAGNARA GP
Citation: A. Tafuri et al., THROMBOPOIETIN PROLIFERATIVE EFFECTS ON ACUTE MYELOID-LEUKEMIA CELLS, Blood, 88(10), 1996, pp. 3219-3219
LONG-TERM SURVIVORS AFTER AML - FOLLOW-UP ON SURVIVAL AND LATE SIDE-EFFECTS OF THE AML5, AML6 AND AML8 STUDIES OF THE EORTC LEUKEMIA COOPERATIVE GROUP AND THE GIMEMA
Authors: MUUS P ZITTOUN R HAYAT M MANDELLI F WILLEMZE R DEWITTE T STRYCKMANS P LABAR B BERNEMAN Z ARCHIMBAUD E PETTI MC JEHN U SOLBU G DARDENNE M SUCIU S
Citation: P. Muus et al., LONG-TERM SURVIVORS AFTER AML - FOLLOW-UP ON SURVIVAL AND LATE SIDE-EFFECTS OF THE AML5, AML6 AND AML8 STUDIES OF THE EORTC LEUKEMIA COOPERATIVE GROUP AND THE GIMEMA, Blood, 88(10), 1996, pp. 311-311
RISK OF LEUKEMIA IN HODGKINS-DISEASE IS SIGNIFICANTLY HIGHER AFTER COMBINED-MODALITY PROGRAMS AND CORRELATES WITH THE TYPE AND DURATION OF CHEMOTHERAPY - A CASE-CONTROL STUDY
Authors: BRUSAMOLINO E ANSELMO AP KLERSY C SANTORO MA ORLANDI E PAGNUCCO G LUNGHI F MAURIZIENRICI R BARONI CD LAZZARINO M BERNASCONI C MANDELLI F
Citation: E. Brusamolino et al., RISK OF LEUKEMIA IN HODGKINS-DISEASE IS SIGNIFICANTLY HIGHER AFTER COMBINED-MODALITY PROGRAMS AND CORRELATES WITH THE TYPE AND DURATION OF CHEMOTHERAPY - A CASE-CONTROL STUDY, Blood, 88(10), 1996, pp. 1163-1163
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>